Fig. 3From: Prognostic role of pretreatment 18F-FDG PET/CT and hematological parameters in relapsed/refractory Hodgkin lymphoma patients treated with immune checkpoint inhibitors and chemotherapy: a dual-center cohort studyKaplan–Meier estimate of PFS in IR2 and IR3 patients according to LYRICBack to article page